China Resources Double-Crane Pharmaceutical Co.,Ltd.
Symbool: 600062.SS
SHH
23.35
CNYMarktprijs vandaag
17.5971
Koers/Winst Verhouding
-0.5329
Koers/Winst Groei Verhouding
24.20B
MRK Kapitalisatie
- 0.01%
DIV Rendement
China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062-SS) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3457 | 2830.7 | 3637.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 240.7 | 200.5 | 803.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 2403.5 | 2362.8 | 2127 | ||||||||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 1562.4 | 1878.6 | 1665.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 215.5 | 92.8 | 92.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 7638.5 | 7165 | 7522.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3852.5 | 3506.6 | 2957.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 906.1 | 935 | 788.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 2482.3 | 2281 | 1899.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3388.3 | 3216 | 2687.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 403.1 | 149.8 | -500.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 192 | 124.7 | 73.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 22.1 | 320.6 | 935.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 7858 | 7317.6 | 6153.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 15496.5 | 14482.5 | 13676.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 696.7 | 744.5 | 847.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 432.9 | 32.1 | 29.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 65.7 | 201.7 | 138.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 29.9 | 232.9 | 35.4 | ||||||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 180.6 | 198.8 | 153.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 1822.3 | 2042.3 | 57.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 364 | 741.1 | 468.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 29.9 | 32.9 | 35.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 3526.1 | 3752.9 | 3199.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 1039.7 | 1043.2 | 1043.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 9670.6 | 8560.9 | 8196.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 380 | 594.3 | 561.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | -175.7 | 103.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 11090.4 | 10022.6 | 9905.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 15496.5 | 14482.5 | 13676.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 699.4 | 707 | 571.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 11789.8 | 10729.6 | 10476.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||||||||||||
Total Investments | 0 | 643.8 | 350.3 | 303.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 462.9 | 265 | 64.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -2753.4 | -2365.3 | -2769.1 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1333 | 1215.4 | 972.1 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 655.5 | 540.6 | 465 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -18.1 | -20.7 | -23.8 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -1705.5 | 36 | 23.8 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -412.6 | -413.5 | -143.5 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -488.7 | -266.2 | -130.7 | ||||||||||||||||||||||||||
cash-flows.row.inventory | 0 | 315.7 | -34.3 | -384.5 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -221.6 | -92.2 | 395.5 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -18 | -20.7 | -23.8 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1798.5 | -16.1 | 47.2 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -604.5 | -525.5 | -491.7 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -127.2 | -409.2 | 36.6 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -2340 | -1350 | -3199.9 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2303 | 2951.7 | 3051.7 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 60.9 | -0.2 | 33.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -707.8 | 666.8 | -569.8 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -9.3 | -6.2 | -47.7 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | -29.7 | 144.7 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -1 | -290.9 | 0 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -300.5 | -801.8 | -302.6 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -17.8 | -337 | -28.3 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -358.3 | -1291.2 | -378.6 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 3.7 | 12.3 | 1.3 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 585.8 | 729.6 | 393.8 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 3216.3 | 2614.7 | 1885.1 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2630.4 | 1885.1 | 1491.3 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1650.8 | 1341.7 | 1340.9 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -604.5 | -525.5 | -491.7 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 1046.3 | 816.1 | 849.2 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 10089.3 | 9446.9 | 9111.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 4948.2 | 4231.8 | 4030 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 5141.2 | 5215.1 | 5081.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -14.5 | 639.7 | 612.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 3684.5 | 3901.5 | 3978.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 8632.6 | 8133.4 | 8008.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 52.9 | 88.5 | 54.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 15.4 | 10.6 | 11.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 97.3 | 8.5 | -15.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -14.5 | 639.7 | 612.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 97.3 | 8.5 | -15.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 15.4 | 10.6 | 11.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 655.5 | 582.3 | 491 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 1456.7 | 1406.1 | 1136.9 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 1554 | 1414.6 | 1121.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 240.6 | 199.3 | 149.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 1333 | 1180.1 | 935.7 |
Vaak gestelde vragen
Wat is China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) totale activa?
China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) totale activa is 15496483691.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.554.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.134.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.147.
Wat is China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) nettowinst (netto-inkomen)?
De nettowinst is 1333029471.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 462877986.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 3684461873.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.